Lee Danner & Bass Inc. Decreases Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Lee Danner & Bass Inc. lessened its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 400,419 shares of the company's stock after selling 2,234 shares during the period. HCA Healthcare makes up 11.2% of Lee Danner & Bass Inc.'s portfolio, making the stock its 2nd biggest position. Lee Danner & Bass Inc. owned approximately 0.16% of HCA Healthcare worth $138,365,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the company. Brighton Jones LLC bought a new position in shares of HCA Healthcare during the 4th quarter valued at about $1,021,000. Fisher Asset Management LLC boosted its position in shares of HCA Healthcare by 37.8% during the 4th quarter. Fisher Asset Management LLC now owns 872 shares of the company's stock valued at $262,000 after purchasing an additional 239 shares in the last quarter. Jones Financial Companies Lllp lifted its position in shares of HCA Healthcare by 81.2% in the fourth quarter. Jones Financial Companies Lllp now owns 2,863 shares of the company's stock worth $859,000 after purchasing an additional 1,283 shares in the last quarter. Keybank National Association OH raised its position in HCA Healthcare by 7.9% during the fourth quarter. Keybank National Association OH now owns 2,755 shares of the company's stock valued at $827,000 after acquiring an additional 201 shares in the last quarter. Finally, Victory Capital Management Inc. raised its position in HCA Healthcare by 4.2% during the fourth quarter. Victory Capital Management Inc. now owns 140,706 shares of the company's stock valued at $42,233,000 after acquiring an additional 5,703 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Up 0.2%

Shares of NYSE:HCA traded up $0.67 during midday trading on Wednesday, hitting $378.27. The stock had a trading volume of 1,215,642 shares, compared to its average volume of 1,595,044. The business's 50-day simple moving average is $373.21 and its 200-day simple moving average is $340.45. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a market cap of $91.00 billion, a P/E ratio of 16.82, a PEG ratio of 1.31 and a beta of 1.47. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter last year, the firm earned $5.36 earnings per share. The company's revenue was up 5.7% on a year-over-year basis. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend was Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

Insider Activity at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an "overweight" rating in a research note on Monday, June 2nd. Robert W. Baird restated a "neutral" rating and set a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Morgan Stanley set a $410.00 price objective on HCA Healthcare and gave the company an "equal weight" rating in a research report on Monday, June 9th. Finally, Stephens raised HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $395.71.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.